Europe — EMA
Orlistat 1 A Pharma
Orlistat, the active ingredient in Orlistat 1 A Pharma, is a lipase inhibitor presented as a unknown/unknown for oral use. It treats obesity by reducing dietary fat absorption in adults.
Request sourcing
What is Orlistat?
Orlistat, the active ingredient in Orlistat 1 A Pharma, is a lipase inhibitor presented as a unknown/unknown for oral use. It treats obesity by reducing dietary fat absorption in adults. GNH USA supplies Orlistat 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Orlistat 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals — pharmacies — clinics through global distribution networks world‑wide.
What is Orlistat used for?
Orlistat is a weight‑management drug that targets the gastrointestinal pathway of fat digestion. It is indicated for: - Obesity: Provides weight loss when combined with a reduced‑calorie, low‑fat diet. - Overweight with comorbidities : Aids to improve metabolic parameters such as blood glucose and lipids. - Weight‑maintenance after significant weight loss : Helps prevent regain of weight when used continuously. - Additional clinical investigations : May be used in research settings for studying fat absorption. - Off‑label use : Occ …
What are the side effects of Orlistat?
Orlistat may produce gastrointestinal‑related adverse events and occasional systemic reactions.
Common Side Effects: - Oily or greasy stool with fecal urgency. - Increased flat bodies and abdominal cramping . - Fat‑t t t t t.\nSerious or Rare ... def
What precautions apply to Orlistat?
Orlistat ...
t
What does Orlistat interact with?
....
